$NBIO Still here. Still waiting. From what I know, some big whales holding millions of shares. They cannot be happy. So I wait with them hoping that something happens here./ok2
$NBIO Something happening again here today. Range of $0.0002-$0.0752 on over 800,000 shares traded. What does someone know here that the rest of us don't?? Anyone have any insight??
$NBIO If there is one lesson to be learned over the last couple days, this one can turn one way or the other very quickly. Still wishing the faithful longs the best of luck./
$NBIO Back to the shelf for this one. Oh well, I’ve long let go of the money I’ve lost here. It would’ve been nice to see Pritumumab get its chance to save lives, but it looks like it’s going nowhere.
$NBIO If PTB is backed by significant financial support or if it is sold to a large company that can fund Phase 2 & 3, then $1 is definitely possible. In 2023, Marble Arch Research specified a price range of $0.60-$2.84.
https://www.nascentbiotech.com/marble-arch-research-what-is-pritumumab-and-how-it-works/
$NBIO From a new poster, asking if $1 is possible. From the company's info, the Glioblastoma market is expected to be $5.68 billion in the next 3-5 years. Lots of ifs, but if the drug can demonstrate efficacy, we have the right partner or the company outright sells, who knows?? Seems like a crazy number today, but do the math, without any dilution to shares, the share price would be unimagineable. But I'm getting ahead of myself. Best of luck to the longs./
$NBIO This study (Mar/2025), I believe validates pritumumab as a viable treatment for brain cancer. It looks to me like this is third party research. This could help give the company the necessary leverage to relist trading for all, (currently expert trading only designation?) and open up exciting new potential for partnerships or sale of the asset. These are my opinions only! Here is the link. Best of luck to the faithful longs./ok2
https://www.nature.com/articles/s41598-025-95360-9
$NBIO J1983 - Looking at the last 2 days of trading: Nov.10/25, $0.09, 40,000 shares sold, Nov.11/25, High $0.1345, Low $0.08, Close $0.084, 211,000 shares sold. Clearly someone is willing to buy shares and this demonstrates that there is value here. I remember reading somewhere that the company was looking for $0.25/share in unlocked potential. I guess we'll see. A call to my broker my shed some light on the trading status. Obviously someone can buy and sell./
$NBIO Thanks ok2buy - I hope so too. I know you’ve been in this longer than I have and I’ve been here 5 years. I’m hoping this amazing drug gets it shot!
$NBIO J1983 - I posted a few days back that I thought something was up. Someone was accumulating shares on the cheap. I tried to buy, I can place an order, but my trading platform ultimately rejects the order. Perhaps, either 1) management has secured new funding or 2) there is a sale of the company or it's assets. Either way, I am hoping that this is good news for existing shareholders. I am going to try to see if we are back in compliance and can be traded again. Best of luck to the faithful longs./
